securities fraud

Law firm files class action against Kyndryl for alleged securities fraud, false financial statements, and internal control failures affecting investors from August 2024 through February 2026.

Paysafe faces securities fraud lawsuit alleging undisclosed high-risk merchant exposure and understated credit reserves during nine-month period through November 2025.

Portnoy Law Firm launches class action against Apollo Global Management alleging undisclosed Epstein communications. Stock declined 5-6% following February 2026 media revelations.

Portnoy Law Firm launches class action lawsuit against Alight, Inc. for allegedly making false revenue statements. Stock plummeted 56% cumulatively across two separate crashes in 2025-2026.

Portnoy Law Firm files class action against $AQST for allegedly misleading investors about Anaphylm FDA prospects. Stock plunged 37% after deficiency disclosure.

Portnoy Law Firm files class action against Camping World Holdings ($CWH) for allegedly making false statements about inventory management and consumer demand between April 2025 and February 2026.

Driven Brands faces securities lawsuit over material accounting errors spanning 2023-2025. Stock fell 40% after February disclosure; investors have until May 8, 2026 to claim lead plaintiff status.

Trip.com faces class action lawsuit alleging securities fraud over undisclosed antitrust risks. Stock fell 19% after China's January 2026 investigation.

$DRVN stock crashed 40% after material accounting restatements spanning 2023-2025. Class action deadline for investors with $100K+ losses set for May 8, 2026.

Soleno Therapeutics ($SLNO) faces class action lawsuit alleging executives failed to disclose material safety concerns with its lead drug DCCR, with lead plaintiff deadline set for May 5, 2026.

Navan faces securities lawsuit over allegedly undisclosed $95 million Q3 sales-marketing expense surge; investors with $100K+ losses have until April 2026 to file.

FDA rejects Corcept's lead drug candidate, triggering 50% stock plunge and securities class action lawsuit. Lead plaintiff deadline set for April 21, 2026.

Enphase Energy shareholders must file lead plaintiff applications by April 20, 2026 in a class action alleging disclosure failures regarding inventory management and tax credit impacts.

Plug Power faces securities fraud lawsuit alleging DOE loan overstatements. Class period: January-November 2025. Investors can seek lead plaintiff status by April 3, 2026.

Driven Brands ($DRVN) restated financials after discovering material errors; stock fell 30.2%. Investors can seek lead plaintiff status until May 8, 2026.

Snowflake faces class action lawsuit alleging false statements about product efficiency, with stock down 18% during June 2023-February 2024 period. Lead plaintiff applications due April 2026.

Driven Brands ($DRVN) stock plummeted 40% after disclosing accounting errors requiring financial restatement. Securities lawsuit filed for investors who bought between May 2023 and February 2026.

Soleno Therapeutics faces securities fraud lawsuit over alleged safety misstatements in DCCR clinical trial. Stock fell 26% following August short-seller report.

Kirby McInerney LLP filed class action lawsuit against $TCOM for allegedly understating regulatory risks before January 2026 stock plunge.

Securities class action filed against NuScale Power over misrepresented ENTRA1 partnership. $495M payment revealed, expenses surged 3,000%, stock down 70% from highs.